Autologous gluteal fat grafting combines body contouring with volume augmentation. The medical goal is to address asymmetrical fat distribution, post-bariatric tissue deflation, or age-related gluteal atrophy. By utilizing biological tissue harvested from the same individual, the procedure avoids foreign-body reactions associated with prosthetic implants while simultaneously contouring donor regions.

The procedure is performed under general anesthesia. Tumescent solution (saline, epinephrine, and lidocaine) is infused into donor fat sites to minimize hemorrhage and facilitate cellular extraction. Liposuction is executed using low-negative-pressure suction to preserve adipocyte cell membranes. Harvested fat undergoes decanting, centrifugation, or specialized filtration to isolate viable fat cells from inflammatory lipids, blood components, and fluid. Using real-time ultrasound guidance or anatomical tactile landmarks, the purified fat is reinjected into the subcutaneous space (strictly above the gluteal fascia) using blunt-tipped cannulas in multiple micro-droplet passes.

Clinical advantages of autologous fat transfer include:

• Biocompatibility using natural host tissue, eliminating risks of capsular contracture or implant rejection
• Dual body-contouring impact: fat reduction at donor harvest sites and volume restoration in recipient regions
• Natural biological integration, soft tissue consistency, and dynamic responsiveness to future biological weight changes
• Minimally invasive incision sites compared to open prosthetic implant surgery

Recovery proceeds through distinct physiological phases:

• Days 1 to 14: Acute inflammatory phase. Patients must avoid direct sitting or lying on the buttocks to prevent mechanical compressive ischemic necrosis of the grafted cells. Continuous specialized compression garments are worn to limit donor site seroma and edema.
• Weeks 2 to 6: Angiogenesis and tissue integration phase. Gradual resumption of light sedentary activities using offloading pressure cushions.
• Months 3 to 6: Stabilization phase. Tissue swelling resolves, and final fat graft retention is established. Normal physical exercise and unrestrained sitting resume.

Autologous gluteal fat grafting addresses several clinical and anatomical conditions, including:

• Gluteal hypoplasia (underdeveloped gluteal musculature and soft tissue)
• Lipodystrophy (disproportionate or irregular subcutaneous fat distribution)
• Anatomical asymmetry resulting from congenital variations, prior trauma, or surgical resection
• Involutional gluteal atrophy secondary to aging or significant post-bariatric weight loss

Pre-operative preparation requires a detailed physical examination, Body Mass Index (BMI) assessment, and routine pre-surgical laboratory evaluation (complete blood count, coagulation profile, metabolic panel). Patients must discontinue all antiplatelet and anticoagulant medications, non-steroidal anti-inflammatory drugs (NSAIDs), and botanical supplements two weeks prior to surgery. Strict smoking cessation is mandatory for a minimum of four to six weeks before and after surgery to prevent tissue necrosis and graft compromise driven by nicotine-induced microvascular vasoconstriction.

Complications range from mild to life-threatening. Common mild side effects include donor site ecchymosis (bruising), localized edema, temporary skin paresthesia, and contour asymmetry. Moderate risks include fat necrosis, oil cysts, localized infection, and hematoma formation. The most critical life-threatening risk is Fat Embolism Syndrome (FES) and Pulmonary Embolism (PE), which occurs if fat is inadvertently injected below the gluteal fascia into the deep intramuscular venous plexus. Modern surgical protocols strictly mandate subcutaneous placement to mitigate this risk.

The clinical trajectory begins with a pre-operative evaluation, including cardiovascular clearance, laboratory screening, and anatomic donor site assessment. On the day of surgery, general anesthesia is administered, followed by tumescent fluid infiltration, donor liposuction, fat purification, and targeted subcutaneous injection using expanded-diameter, blunt-tipped cannulas. The post-operative recovery requires strict pressure avoidance on the grafted area for 2 to 6 weeks, combined with compression garment compliance to manage edema and support vascularization of transferred fat cells.